Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy

Semin Oncol Nurs. 2019 Jun;35(3):253-260. doi: 10.1016/j.soncn.2019.04.006. Epub 2019 Apr 30.

Abstract

Objective: To describe the known predictors and pathophysiological mechanisms of chronic painful chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors and the challenges in assessing and managing it.

Data sources: PubMed/Medline, CINAHL, Scopus, and PsycINFO.

Conclusion: The research on chronic painful CIPN is limited. Additional research is needed to identify the predictors and pathophysiological mechanisms of chronic painful CIPN to inform the development of assessment tools and management options for this painful and possibly debilitating condition.

Implications for nursing practice: Recognition of the predictors of chronic painful CIPN and proactive CIPN assessment and palliative management are important steps in reducing its impact on physical function and quality of life.

Keywords: Cancer; Centralized pain; Chemotherapy-induced peripheral neuropathy; Chronic pain; Neuropathic pain; Polyneuropathy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Pain / chemically induced*
  • Pain Management / methods*
  • Peripheral Nervous System Diseases / chemically induced*
  • Quality of Life

Substances

  • Antineoplastic Agents